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Abstract. 
 
Embryonic development requires cell migra-
tion in response to positional cues. Yet, how groups of 
cells recognize and translate positional information into 
morphogenetic movement remains poorly understood. 
In the developing kidney, the ureteric bud epithelium 
grows from the nephric duct towards a group of poste-
rior intermediate mesodermal cells, the metanephric 
mesenchyme, and induces the formation of the adult 
kidney. The secreted protein GDNF and its receptor 
RET are required for ureteric bud outgrowth and sub-
sequent branching. However, it is unclear whether the 
GDNF–RET pathway regulates cell migration, prolif-
eration, survival, or chemotaxis. In this report, we have 
used the MDCK renal epithelial cell line to show that 
activation of the RET pathway results in increased cell 
motility, dissociation of cell adhesion, and the migra-
tion towards a localized source of GDNF. Cellular re-
sponses to RET activation include the formation of 
lamellipodia, filopodia, and reorganization of the actin 
cytoskeleton. These data demonstrate that GDNF is a 
chemoattractant for RET-expressing epithelial cells 
and thus account for the developmental defects ob-
served in RET and GDNF mutant mice. Furthermore, 
the RET-transfected MDCK cells described in this re-
port are a promising model for delineating RET signal-
ing pathways in the renal epithelial cell lineage.
Key words: GDNF • RET • kidney development • 
chemoattraction • MDCK cells
 
D
 
URING
 
 
 
embryonic development, secreted signaling
molecules can specify the fates of adjacent cells,
stimulate or inhibit cellular proliferation, and act
as attractants or repellents for axonal guidance. The devel-
oping kidney is a well-studied paradigm for signaling in-
teractions between epithelial and mesenchymal tissues
(Saxen 1987; Lechner and Dressler, 1997). The kidney, or
metanephros, becomes induced when the ureteric bud, an
outgrowth of the nephric duct epithelium, contacts the meta-
nephric mesenchyme, a group of posterior, intermediate
mesodermal cells that are already predetermined to form
renal epithelium. Classical tissue recombination experi-
ments had demonstrated that the ureteric bud sends per-
missive signals to promote aggregation of the mesenchyme
and phenotypic conversion to renal epithelium (Grobstein
1955, 1956). Thus, much of the tubular epithelium of the
nephron is derived from mesenchymal cells. Reciprocally,
the metanephric mesenchyme emits signals that instruct the
ureteric bud to proliferate and undergo branching mor-
phogenesis, to induce new nephrons along the radial axis of
the growing kidney, and to generate the collecting duct system.
The receptor tyrosine kinase RET is an essential com-
ponent of the signaling pathway which regulates ureteric
bud outgrowth and branching. RET is expressed along the
nephric duct and in the newly formed ureteric bud, but be-
comes restricted to the growing tips of the bud as branch-
ing morphogenesis progresses (Pachnis et al., 1993; Avan-
taggiato et al., 1994). Homozygous RET-null mice exhibit
renal agenesis due in large part to an inhibition of ureteric
bud outgrowth (Schuchardt et al., 1994, 1996). In a low
percentage of mice, the ureteric bud is formed but branch-
ing is inhibited. Strikingly, the metanephric mesenchyme
of RET-null mice is still able to respond to inductive sig-
nals (Schuchardt et al., 1996). A similar renal phenotype
was observed in homozygous mice carrying a null allele of
the gene encoding glial cell-derived neurotrophic factor
(GDNF)
 
1
 
 (Moore et al., 1996; Pichel et al., 1996; Sanchez
et al., 1996). GDNF expression is localized to the meta-
nephric mesenchyme at early stages and is repressed in the
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The Journal of Cell Biology, Volume 142, 1998 1338
 
induced mesenchyme as epithelial conversion occurs
(Hellmich et al., 1996). However, GDNF remains re-
stricted to mesenchyme in the peripheral nephrogenic
zone as the kidney develops. GDNF is able to stimulate
branching morphogenesis in the kidney (Vega et al., 1996)
and is sufficient to induce ectopic ureteric buds from the
nephric duct (Sainio et al., 1997). Moreover, GDNF can
activate the RET tyrosine kinase domain (Trupp et al.,
1996; Vega et al., 1996). However, binding of GDNF to
RET and activation of the catalytic domain requires a high
affinity, GPI-linked coreceptor, GFR
 
a
 
-1 (Jing et al., 1996;
Treanor et al., 1996; Sanicola et al., 1997), which is ex-
pressed in both mesenchyme and ureteric bud epithelium
(Sainio et al., 1997).
In the embryonic kidney, RET-expressing ureteric bud
epithelial cells (Pachnis et al., 1993) grow towards the meta-
nephric mesenchyme, which expresses GDNF (Hellmich
et al., 1996). In the gut, RET-expressing neural crest cells
migrate into the developing gut endoderm, also expressing
GDNF, to generate the enteric neurons of the intestinal
tract. How activation of RET affects the ureteric bud epi-
thelium to promote directional growth remains obscure.
Localized proliferation and physical constraints could
push the growing bud out of the existing duct. Differences
in the composition of extracellular matrix in the meta-
nephric mesenchyme, relative to surrounding mesoderm,
could provide for a favorable environment for bud exten-
sion in response to growth factors. Alternatively, the GDNF–
RET pathway could provide and translate positional guid-
ance cues for migrating ureteric bud epithelial cells.
The growing tip of the ureteric bud epithelium is a
highly specialized tissue that expresses, in addition to
RET, a number of other markers, such as wnt-11 (Kispert
et al., 1996) and c-ros (Tessarollo et al., 1992), not found in
the more mature stalk of the epithelium. Unfortunately,
immortalized cell lines that correspond this growth zone of
the bud have not been identified. In this report, we have
used the established renal cell line MDCK to examine the
effects of RET activation on cell morphology, motility,
and migratory potential. The MDCK cell is morphologi-
cally most like renal distal tubular epithelium (Leighton et
al., 1969; Rindler et al., 1979) and has retained the ability
to form tubules in three-dimensional culture systems
(Montesano et al., 1991). In RET-transfected MDCK-
derived clones, RET could be activated in a ligand-inde-
pendent manner by overexpressing the protein or in a
ligand-dependent manner by the addition of GDNF and
soluble GFR
 
a
 
-1. Activation of RET resulted in cell scat-
tering, increased cell motility, and cell migration towards a
localized source of GDNF. These effects are accompanied
by changes in cellular morphology, including the redistri-
bution of actin stress fibers and focal adhesion molecules
and the formation of lamellipodia and filopodia. These
data support the hypothesis that GDNF is a target-derived
guidance cue for epithelial cell migration into the meta-
nephric mesenchyme.
 
Materials and Methods
 
Cell Lines
 
MDCK cells, clone 3B5, were cultured in a 5% CO
 
2
 
/95% air environment
with DME containing 10% fetal bovine serum. Subconfluent cells in 10-
cm dishes were transfected with pCMVRET-HA/neo construct using lipo-
fectamine (Life Technologies, Inc., Gaithersburg, MD) reagent as de-
scribed by the manufacturer. Stable lines were selected in 400 
 
m
 
g/ml G418.
The kinase mutant was constructed by site-directed mutagenesis which
converts lysine 758 to methionine (Liu et al., 1996). To observe RET acti-
vation, cells were incubated with DME containing 10 or 1% serum for 3 d
before immunoprecipitation. Alternatively, subconfluent cells were cul-
tured in 10% serum supplemented with 100 ng/ml of soluble, recombinant
human GFR
 
a
 
-1 (previously known as GDNFR-
 
a
 
 or RETL1) in the pres-
ence or absence of 50 ng/ml recombinant human GDNF (Promega Corp.,
Madison, WI) for a specified time from 5 min to 24 h. RET immunopre-
cipitation and Western blotting with anti-phosphotyrosine (pTyr) and
anti-HA antibodies was done as described previously (Vega et al., 1996).
Anti–E-cadherin staining was done as described (Ryan et al., 1995; Cho et
al., 1998). After fixing in 4% paraformaldehyde for 10 min, and rinsing in
PBS/0.1% Tween-20, cells were stained with FITC-phalloidin (1 
 
m
 
g/ml,
Sigma Chemical Co., St. Louis, MO) in PBS/0.1% Tween-20/2% goat se-
rum. Focal adhesion complexes were stained using anti-vinculin mouse
monoclonal antibody (Sigma Chemical Co.) at a dilution of 1:400 and a
Texas red-conjugated goat anti–mouse secondary antibody (Molecular
Probes, Inc., Eugene, OR) at 1:200.
Cell proliferation assays were done on either plastic-coated dishes or
on thin collagen gels, in the presence or absence of GDNF/GFR
 
a
 
-1. To
examine the effects of RET activation by ligand, 10,000 cells were plated
in six-well dishes at day 0 and counted every 2 d. Three independent ex-
periments were averaged and the standard error calculated.
 
Cell Migration Assays
 
A modified Boyden chamber assay was used to assess cell migration
through filters. To evaluate the migration potential, RET-2, RET-9, and
KM cells were cultured with 10 or 1% serum for 3 or 5 d. Cells were
washed, trypsinized, and then cell numbers were counted under a hemocy-
tometer. For ligand-dependent cell migration, 10
 
5
 
 cells were plated onto
the polyethylene terephthalate (PET) filters containing 8-
 
m
 
m pores (Fal-
con Plastics, Cockeysville, MD) with media supplemented with 10% se-
rum and 100 ng/ml of GFR
 
a
 
-1. GDNF was added to the bottom chamber
or both the bottom and top chambers at either 10 or 50 ng/ml. After a 24-h
incubation, cells on top of the filters were scraped and the remaining cells
on the bottom side of the filter were fixed, stained, and then counted
under the light microscope. Five fields were counted at 100
 
3 
 
and the av-
erage number of cells and standard deviation from the mean were calcu-
lated. Each condition was repeated with at least three independent exper-
iments. The KM cells did not migrate across the filter under any of the
experimental conditions used.
 
Chemoattraction Assays
 
Preparation of type I collagen gel has been described by Montesano et al.
(1991). A six-well plate was coated with 0.5 ml of collagen gel (Collabora-
tive Biomedical Products, Waltham, MA) per well. Heparin
 
-
 
acrylamide
beads (Sigma Chemical Co.) were washed in PBS and incubated with 10
ng/
 
m
 
l recombinant GDNF (Promega Corp.) or BSA for 1 h. Beads were
washed in PBS and then inserted in type I collagen gel before the gel so-
lidified. The collagen gel helps to maintain the chemical gradient of the
ligands in their local microenvironment created by the beads. Ret9 and
KM cells were seeded on the surface of the gel at 20,000 cells/well with
media containing 10% serum and 100 ng/ml of soluble GFR
 
a
 
-1. Cells
around the beads were photographed over time at 8-h intervals.
 
Organ Culture
 
Kidneys were cultured and stained as described (Vega et al., 1996). DME
supplemented with 10% serum was used in all organ cultures. GDNF and
BSA beads were prepared as described above. Kidney rudiments were
dissected from 11.5-d-old embryos, at the time when the ureteric bud had
formed a T-shaped structure. A single bead was placed at one side of the
embryonic kidney. After 2 d, kidneys were fixed in cold methanol for 10
min, washed in PBST (PBS containing 0.1% Tween 20), and then stained
with a pancytokeratin monoclonal (Sigma Chemical Co.) to visualize the
ureteric bud branching pattern. 
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Results
 
To develop a model system for examining the effects of
RET activation on renal epithelial cells, the MDCK cell
line was transfected with expression vectors encoding ei-
ther the human wild-type RET or a kinase-deficient mu-
tant form (KM), both containing a hemagglutinin (HA)
epitope tag at the carboxyl terminus (Liu et al., 1996). The
MDCK cells have been used extensively as a model epi-
thelial cell type and are well characterized with respect to
their origin from the distal part of the nephron (Rindler et
al., 1979). Furthermore, MDCK cells are able to form epi-
thelial cysts and tubules in three-dimensional collagen gels
(Montesano et al., 1991). Multiple RET-expressing cell
lines were identified by Western blotting using an anti-HA
antibody. The wild-type RET-expressing MDCK clonal
lines used for this study were Ret2 and Ret9, where Ret9
expressed four- or fivefold more protein than Ret2 (data
not shown). The cell line KM expressed the kinase mutant
form of RET at levels comparable to Ret2.
 
RET Activation Promotes Scattering but
Not Proliferation
 
Initial experiments designed to characterize the growth
properties of the Ret2, Ret9, and KM cells in either 10 or
1% serum revealed a high level of RET activation upon
prolonged growth in 1% serum (Fig. 1 
 
A
 
). Phosphoryla-
tion of RET was assayed by immunoprecipitation with
anti-HA followed by Western blotting with an anti-pTyr
antibody. Phosphorylation of the larger 170-kD protein is
 
indicative of RET activation. Under normal culture condi-
tions in 10% fetal calf serum, Ret9 cells had a low basal
level of phosphorylated RET (Fig. 1 
 
A
 
). However, when
the same cells were cultured in 1% serum, the level of acti-
vated RET increased dramatically as indicated by high
levels of the 170-kD phosphorylated RET protein in the
Ret9 cells but not in the KM cells. Northern blot analysis
indicated a three- to fivefold increase in RET mRNA
driven from the cytomegalovirus (CMV) promoter (data
not shown) and Western blotting using anti-HA or anti-
RET antibodies indicated increased amounts of RET pro-
tein (Fig. 1 
 
A
 
). Ret2 and Ret9 cells were able to autoacti-
vate RET in low serum, most probably due to increased
expression from the CMV promoter used in the expres-
sion vectors and subsequent autodimerization of the RET
protein.
To activate RET in a more controlled, ligand-dependent
manner, both GDNF and soluble GFR
 
a
 
-1 were required.
Neither Ret2 nor Ret9 cells activate the RET protein in
response to GDNF alone since they do not express the
necessary coreceptor protein, GFR
 
a
 
-1. However, when
soluble, recombinant GFR
 
a
 
-1 was added together with
GDNF, and RET phosphorylation was observed in Ret9
cells cultured in 10% serum (Fig. 1 
 
B
 
). Maximum activa-
tion of RET was observed after 20 h of GDNF/GFR
 
a
 
-1
treatment. Although it is not entirely clear why activation
was not observed sooner, this extended lag period may re-
flect the kinetics of GDNF/GFR
 
a
 
-
 
1
 
 association in solu-
tion, rather than at the cell surface where the GPI-linked
GFR
 
a
 
-1 is usually located.
To determine the effects of RET activation on prolifera-
tion, growth curves were determined in 10 and 1% serum
and in response to ligands on various culture surfaces (Fig.
2). In 10% serum, Ret9, Ret2, and the KM cells grew at
similar rates (Fig. 2 
 
A
 
). In 1% serum, the Ret9 cells that
exhibited the highest amounts of phosphorylated RET did
not proliferate any faster than Ret2 or KM cells. The pa-
rental MDCK grew at the same rate as the KM cells (data
not shown). If anything, Ret9 cells exhibited a slight de-
crease in cell number, relative to controls, after 3 d in cul-
ture upon RET activation in low serum. Activation of
RET by exogenous ligands also did not significantly in-
crease cell proliferation (Fig. 2 
 
B
 
). On plastic tissue cul-
ture dishes, there was no increase in growth of Ret9 cells
when cultured in the presence of GDNF/GFR
 
a
 
-1. On the
surface of collagen gels, no significant differences on pro-
liferation of Ret9 cells were observed upon GDNF/GFR
 
a
 
-1
treatment after 4 or 6 d. Given that the doubling time of
the MDCK-derived lines is 
 
z
 
12 h, even relatively small
differences in proliferation rates should become apparent
after 6 d.
To develop biological assays for RET-expressing deriva-
tive cell lines, the Ret2, Ret9, KM, and parental MDCK
cells were cultured under a variety of conditions. In high
serum all cells grew as islands on plastic and exhibit tight
associations (Fig. 3 
 
A
 
). However, in low serum or in the
presence of GDNF/GFR
 
a
 
-1, Ret2 and Ret9 cells, but not
KM cells, become dissociated and sent out long cellular
processes. The cell scattering observed with activated
RET could be quantified by counting the number of cells
that have lost contact with their neighbors. Approximately
60% of the Ret9 cells and 12% or the Ret2 cells become
Figure 1. (A) Autophosphorylation of RET in response to low
serum. Ret9 and KM cells were cultured in 10 or 1% serum and
then RET was immunoprecipitated with anti-HA and detected
with anti-HA or anti-pTyr. (B) Ligand-dependent phosphoryla-
tion of RET. Ret9 cells cultured in 10% serum and 100 ng/ml
GFRa-1 were exposed to 50 ng/ml GDNF for the indicated times
in hours; the control culture 202 did not receive GFRa-1 or
GDNF. 
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scattered when cultured in 1% serum, whereas less than
2% of the KM cells exhibit scattering under similar condi-
tions. In addition to cell scattering, RET activation in low
serum promoted the outgrowth of long cellular processes,
particularly evident when the cells were seeded in three-
dimensional collagen gels (Fig. 3 
 
A
 
). Similar results were
obtained when Ret9 cells were cultured with GDNF and
GFR
 
a
 
-1 (Fig. 3 
 
B
 
). Cells became detached and sent out
long cellular processes, particularly evident at the edges of
cellular islands. KM (Fig. 3 
 
B
 
) and parental MDCK (data
not shown) cells did not exhibit any response to GDNF/
GFR
 
a
 
-1. Scattering of Ret9 cells in response to RET acti-
vation was accompanied by a loss of E-cadherin staining at
the cell surface (Fig. 4). In contrast, KM cells became flat-
tened out in low serum but maintained their E-cadherin–
positive junctions.
 
Increased Cell Motility of RET-activated Cells
 
Given the increased scattering upon RET activation, the
motility of Ret9 and KM cells was examined by testing
their ability to migrate through a porous filter. Ret9 and
KM cells were seeded on Transwell inserts containing
PET filters with an 8-
 
m
 
m pore size, cultured in 10% serum
supplemented with soluble GFR
 
a
 
-1, and then allowed to
become confluent. Increasing amounts of GDNF were
added to the underside of the filters, or bottom chamber,
or to the top chamber, and the cells cultured for an addi-
tional 24 h. The number of cells migrating through the fil-
ter were scored by light microscopy (Fig. 5). The KM cells
were unable to migrate through the filter under any of the
conditions analyzed (data not shown). Ret9 cells were able
to migrate through the filter at a low basal rate of 
 
z
 
40
cells per field of view. Addition of 10 ng/ml GDNF to the
bottom chamber showed a twofold increase in Ret9 cells
migrating through the filter. If 10 ng/ml GDNF was added
to both chambers, this twofold increase was reduced
slightly. However, at 50 ng/ml of GDNF in the bottom
chamber, the number of Ret9 cells migrating through was
increased fourfold. This fourfold increase was significantly
reduced if 50 ng/ml GDNF was added to both top and bot-
tom chambers. Addition of 50 ng/ml GDNF to the top
chamber only reduced the transfilter migration even fur-
ther. The data demonstrate increased cell motility upon
activation of RET. These data also suggest that transfilter
migration of Ret9 cells is due, at least in part, to chemo-
taxis, since fewer cells were observed migrating through
the filter when GDNF was present in both chambers than
when GDNF was present in the bottom chamber only.
Cell motility and scattering is mediated by the reorgani-
zation of the cytoskeleton. To examine reorganization of
the actin filaments and focal adhesion complexes, Ret9
cells cultured in the presence or absence of GDNF/GFR
 
a
 
-1
were stained with FITC-phalloidin and antivinculin anti-
bodies (Fig. 6). Control Ret9 cells contain many stress fi-
bers running along the entire length of the cells, with par-
ticularly thick staining bundles along the periphery of the
epithelial islands (Fig. 6 
 
A
 
). After RET activation, stress
fibers are much less apparent (Fig. 6, 
 
B
 
 and 
 
D
 
), strong ac-
tin staining is seen in the lamellipodia, and filopodia are
seen all along the cell membrane (Fig. 6 
 
E
 
). Actin poly-
merization is also seen in membrane ruffles after GDNF/
Figure 2.  ( A ) Proliferation
curves of Ret9, Ret2, and
KM cells in 10 or 1% serum.
Cells were seeded at 100,000
cells per 60-mm dish and
counted over 6 d. Cell num-
bers were averaged from
three independent experi-
ments. (B) Effect of GDNF/
GFRa-1 on proliferation of
Ret9 and KM cells. Cells
were seeded at 10,000 cells
per well in six-well dishes in
the presence (1) or absence
of 50 ng/ml GDNF and
counted every 2 d. Cells were
seeded either on plastic or
collagen gels as indicated.
Cell numbers represent aver-
ages from three independent
experiments. The error bars
represent one standard devi-
ation from the mean. 
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GFR
 
a
 
-1 treatment (Fig. 6 
 
D
 
). Focal adhesion complexes
are found at the termini of stress fibers and are randomly
distributed along the untreated cells (Fig. 6 
 
F
 
) but become
localized to the leading edges of extending lamellipodia
upon RET activation (Fig. 6, 
 
G
 
 and 
 
H
 
). These data dem-
onstrate that RET activation results in the redistribution
of focal adhesion complexes, the formation of filopodia
and lamellipodia, and the reorganization of the actin cy-
toskeleton.
 
GDNF Is a Chemoattractant
 
As the activation of RET increased motility, we designed
experiments to examine if the RET-expressing cells could
respond to and migrate towards a localized source of
GDNF. Heparin
 
-
 
acrylamide beads were soaked in GDNF
or BSA and placed in a 0.3% collagen gel that covered the
bottom of the culture dish. Ret9 and KM cells were seeded
on top of the gel at a low density (20,000 cells/well), sup-
plemented with GFR
 
a
 
-1, and then observed over 4 d (Fig.
7). After 2 d in culture, Ret9 cells near the beads exhibited
scattering and sent out processes, whereas KM cells
showed no observable phenotype. After 3 d in culture on
collagen gels, Ret9 cells surrounded the area of the GDNF
beads (Fig. 7 
 
B
 
) but not the BSA control beads. After 4 d
Figure 3. Morphology of RET expressing MDCK cells. (A) Ret9
and KM cells grown in 10% serum, 1% serum, or on collagen
gels. Arrows, cellular processes exclusive to Ret9 cells and clearly
evident in collagen cultures. (B) Effect of GDNF/GFRa-1 on
morphology of Ret9 and KM cells on plastic.
 
Figure 4.
 
Immunostaining for E-cadherin shows tight cellular
junctions in KM and Ret9 cells grown in 10% serum. Ret9 cells
loose E-cadherin staining in 1% serum. E-cadherin staining used
rat monoclonal DECMA-1 (Sigma Chemical Co.) as described
previously (Ryan et al., 1995; Cho et al., 1998). 
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in culture, Ret9 cells could be seen attached to the GDNF
beads (Fig. 7 
 
E
 
) but not to BSA-coated beads (Fig. 7 
 
F
 
).
KM cells did not exhibit any migration or attraction to
GDNF beads and the control BSA beads were essentially
inert. Thus, Ret9 cells were able to sense local concentra-
tions of GDNF and migrate towards their source. This at-
traction was dependent on the kinase activity of RET and
required the GFR
 
a
 
-1 coreceptor. In kidney organ cul-
tures, GDNF-soaked beads were placed on one side of an
E11.5 isolated kidney rudiment and cultured for 2 d (Fig. 7
 
G
 
). The ureteric bud grew towards and completely sur-
rounded the GDNF beads. Ectopic ureteric bud branches
growing from the stalk of the bud were also routinely ob-
served (Fig. 7 
 
G
 
, 
 
arrow
 
). Our results obtained with kidney
organ cultures were essentially identical to the previously
reported ability of GDNF to induce ectopic ureteric buds
(Sainio et al., 1997). Thus, the ureteric bud epithelium
could migrate towards a localized concentration of GDNF,
in concordance with the Ret9 cell data.
 
Discussion
 
Much of the available data regarding GDNF signaling and
function has been obtained in neuronal cells where effects
on differentiation and survival are pronounced (for review
see Lapchak et al., 1996; Lindsay and Yancopoulos, 1996).
However, in addition to neural defects, both GDNF and
RET mutant mice exhibit severe renal agenesis because
the ureteric bud fails to grow out of the nephric duct epi-
thelium (Moore et al., 1996; Pichel et al., 1996; Sanchez et
al., 1996). Since RET signaling in the renal epithelium has
not been studied in detail and cells corresponding to the
ureteric bud are not readily available, we have developed
RET-expressing MDCK cell lines so that the morphologic
effects of RET signaling can be examined in a culture sys-
tem. The MDCK cell lines are an excellent tissue culture
model for a polarized renal-derived epithelium that can
respond to both mitogenic and tubulogenic factors. The
data presented in this report demonstrate that activation
of RET in MDCK cells results in increased cell motility
and migration. The RET-expressing epithelial cells are
able to migrate towards a localized source of GDNF, indi-
cating chemoattraction at the cellular level.
The ureteric bud grows out of the caudal end of the
nephric duct, adjacent to the metanephric mesenchyme.
Although RET is expressed along the entire length of the
duct at this time (Pachnis et al., 1993), GDNF is found
only in the mesenchyme (Hellmich et al., 1996; Sainio et
al., 1997). In organ culture, GDNF beads can induce ec-
topic ureteric buds (Sainio et al., 1997), demonstrating that
GDNF is sufficient for outgrowth. The data of Sainio et al.
(1997), together with our own MDCK chemoattraction
Figure 5. Transfilter chemotaxis assay of Ret9 cells. Cells were
cultured in 10% serum and 100 ng/ml GFRa-1. After confluence,
10 or 50 ng/ml of GDNF was added to one or both chambers of
the transfilter insert as indicated. The average number of cells per
field is shown from a representative experiment with the error
bars represent one standard deviation. Experiments were done in
triplicate.
Figure 6.  Effects of RET Activation on the actin cytoskeleton
and focal adhesions. Ret9 cells cultured in media alone (A, C, and
F) or with GDNF/GFRa-1 (B, D, E, G, and H). Cells were
stained with FITC-phalloidin or antivinculin (red). Untreated
cells exhibit prominent stress fibers (A and C), whereas RET ac-
tivation results in fewer stress fibers and actin accumulation in
lamellipodia (B) and at focal points along the cell membrane (D).
Actin staining also reveals many filapodia (E, arrow) along the
membrane of RET-activated cells. Control cells exhibit vinculin
staining (F, red) at the termini of stress fibers. RET activation (G
and H) results in vinculin staining at the leading edges of newly
formed lamellipodia (arrows).Tang et al. The RET–GDNF Pathway Regulates Cell Migration 1343
and migration studies, clearly demonstrate that GDNF is a
guidance cue for directional growth of the ureteric bud ep-
ithelium. This interpretation is supported by genetic data
from both GDNF and RET mutants. Other genes that af-
fect the ureteric bud in a noncell autonomous manner in-
clude the Wilms’s tumor suppressor gene, WT1, which is
expressed in the mesenchyme, but not in the ureteric bud,
yet inhibits ureteric bud outgrowth (Kreidberg et al.,
1993). Thus, WT1 may be required for GDNF expression
and/or maintenance of the mesenchymal cells in a viable
state.
Migration of MDCK cells in response to RET activation
is accompanied by the outgrowth of cellular processes, or
lamellipodia, in scattered epithelial cells. These processes
have also been observed in RET-transformed neuronal
cells (van Weering and Bos, 1997). In addition to playing a
fundamental role in cell migration (Cooper, 1991), these
cellular processes might sense local concentrations of
ligands and thus direct cells to their source. In fact, we
have observed cellular processes extending towards and
attaching to the GDNF-soaked beads in culture. All of
these effects are dependent on the kinase activity of RET
and correlate with the level of RET phosphorylation. The
effects on cell morphology observed upon RET activation
are very similar to those obtained with hepatocyte growth
factor (HGF) (Ridley et al., 1995) and may be mediated, at
least in part, by common signaling pathways downstream
of the small GTP-binding proteins Ras, Rac, Rho, and/or
Cdc42 (Tapon and Hall, 1997). In MDCK cells, the HGF-
mediated rearrangement of the actin cytoskeleton and cell
spreading requires Ras and Rac, whereas Rho appeared
not to be required for motility (Ridley et al., 1995).
Whether RET acts through any or all of these GTP-bind-
ing proteins remains to be seen.
Cell scattering has also been observed in neuroepithe-
lioma cells upon expression and activation of an EGFR/
RET chimeric receptor (van Puijenbroek et al., 1997) and
resulted in sustained activation of ERK2. Yet constitu-
tively activate, oncogenic forms of RET, corresponding to
MEN2B mutations, decrease cell adhesion and increasing
metastatic potential while activating the Jun amino-termi-
nal kinase pathway and not ERK1 or ERK2 (Marshall et
al., 1997). RET signaling has been studied in some detail
using chimeric and/or oncogenic forms of RET and has
pointed to interactions with a variety of downstream tar-
gets, including Shc, Grb2 (Borello et al., 1994), phospholi-
pase C-g (Borello et al., 1996), Grb7 (Pandey et al., 1996),
Grb10 (Pandey et al., 1995), and enigma (Durick et al.,
1996). Yet, it is unclear how many of these potential RET-
binding proteins function in migration and chemoattrac-
tion during ureteric bud growth. The MDCK cell system
described in this report can now be used to assay various
RET mutants in potential docking sites and help to delin-
eating downstream RET signaling pathways specific for
epithelial cells.
Activation of RET in MDCK cells does not elicit a sig-
nificant mitogenic response under any of the conditions
tested. Thus, the cells observed nearing the GDNF beads
over time, in the chemoattraction experiments, are due to
cell detachment and migration from surrounding cellular
islands. In vivo, the outgrowth of the duct must also be
coupled to cell proliferation. Indeed, increased cell divi-
sion is observed in ureteric bud tips upon localized GDNF
application (Pepicelli et al., 1997). However, MDCK cells
do not proliferate in response to either ligand-dependent
or -independent RET activation. In contrast, HGF stimu-
lates both proliferation and motility in MDCK cells
through the c-met receptor tyrosine kinase (for review see
Gherardi and Stoker, 1991). Thus, the metanephric mes-
enchyme could be providing additional factors, such as
HGF, to increase proliferation of ureteric bud cells and
this proliferative effect is more pronounced as GDNF-
dependent branching morphogenesis is stimulated. Kidney
organ culture experiments also point to a role for HGF in
branching morphogenesis (Santos et al., 1994; Woolf et al.,
1995). However, neither HGF (Schmidt et al., 1995; Ue-
hara et al., 1995) nor c-met (Bladt et al., 1995) homozy-
gous mutant mice exhibit morphologically detectable ure-
teric bud defects.
Figure 7. Chemoattraction assay. (A) Ret9 cells adjacent to a
GDNF bead at 1 d in culture. (B) Same view as A after 3 d. (C)
KM cells adjacent to a GDNF bead at 1 d in culture. (D) Same
area as C after 3 d. (E) High magnification of Ret9 cells attached
to a GDNF bead after 4 d in culture. (F) Ret9 cells do not attach
to a BSA-coated bead after 4 d. (G) E11 kidney rudiment cul-
tured for 2 d with a GDNF bead (outlined) at one side of the ure-
teric bud. Note ectopic branch coming from the stalk of the ure-
ter (arrow), where branches are normally not seen. (H) E11
kidney cultured for 2 d with a BSA bead (outlined) at one side.The Journal of Cell Biology, Volume 142, 1998 1344
The migration of the ureteric bud must require a precise
balance between the attraction to GDNF and the reten-
tion of adhesion among epithelial cells. In our culture con-
ditions, MDCK cells become scattered as they migrate. At
first glance, this would not appear to be the case for ure-
teric bud epithelium, otherwise its essential epithelial
character would be disturbed. However, it has been re-
ported that there is a degree of delamination from the tips
of the ureteric bud epithelium (Qiao et al., 1995), closest
to the source of GDNF, and that these delaminated cells
can contribute to other parts of the nephron previously
thought to arise solely from the mesenchyme. Thus, the
chemoattraction model can explain not only the GDNF
and RET mutant phenotypes but also the recent cell lin-
eage studies in the developing kidney. Furthermore, acti-
vating RET mutations have been associated with familial
medullary thyroid carcinoma (Hofstra et al., 1994; Mulli-
gan et al., 1994) in which parafollicular C cells delaminate
from the epithelial follicle and migrate into the surround-
ing stroma (Ball et al., 1996). Thus, the activated RET
pathway may also promote the ability of dysplastic cells to
become metastatic and invade surrounding tissue.
The data presented in this report indicate several novel
activities not previously associated with the GDNF–RET
pathway. Activation of RET in the MDCK cell system
clearly alters the adhesion and migration ability, most
probably due to cytoskeletal and focal adhesion complex
rearrangements and lamellipodia formation. These mi-
grating cells are attracted to localized sources of GDNF,
thus making the RET-transfected MDCK cell an excellent
model for examining RET signaling and chemoattraction
at the cellular level.
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